Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testingAndreas Rothfuß, Hans‐Jörg Martus, Madoka Nakajima et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010Cited by 106
Follow‐up actions from positive results of in vitro genetic toxicity testingKerry L. Dearfield, Kristine L. Witt, Véronique Thybaud et al.|Environmental and Molecular Mutagenesis|2010Cited by 60
Evaluation of the nitrosamine impurities of <scp>ACE</scp> inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potentialJennifer Cheung, Maik Schuler, Krista L. Dobo et al.|Environmental and Molecular Mutagenesis|2024Cited by 14
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakesDavid J. Ponting, Robert Thomas, Andreas Czich et al.|Regulatory Toxicology and Pharmacology|2024Cited by 13
Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity dataRobert A. Jolly, Raechel Puglisi, Alejandra Trejo-Martin et al.|Regulatory Toxicology and Pharmacology|2026Cited by 3